Body Mass Index Strongly Linked to Adiposity for Children Aged 8 to 19 Years
By Elana Gotkine HealthDay Reporter
MONDAY, June 3, 2024 -- For children aged 8 to 19 years, body mass index (BMI) is strongly related to high levels of adiposity, according to a study published online June 3 in Pediatrics.
David S. Freedman, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined the cross-sectional relation of BMI to adiposity from 2011 through 2018 among 6,923 8- to 19-year-olds in the National Health and Nutrition Survey. Participants underwent dual-energy X-ray absorptiometry. Adiposity was expressed as fat mass index (FMI) and percentage body fat (percentage fat).
The researchers found that 90 to 94 percent of the variability of FMI and lean mass index (LMI) were accounted for by age and BMI in each sex, while the associations with percentage fat were weaker. The screening abilities of a BMI ≥ CDC 95th percentile for high levels of adiposity and LMI were examined; cut points were selected so that the prevalences of high values of these variables would be similar to that for high BMI. Of participants with a high BMI, 88 and 76 percent had a high FMI and high percentage fat, respectively. Compared with those with lower BMIs, those with a high BMI were 29 times more likely to have a high FMI; the comparable relative risks were 12 and 14 for high percentage fat and high LMI, respectively.
"Our findings provide further evidence of the utility of BMI in research and clinical care," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2024
Read this next
In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity
TUESDAY, May 20, 2025 -- For children with acute lymphoblastic leukemia (ALL), longer duration of overweight or obesity is associated with lower overall and event-free survival...
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery
THURSDAY, May 15, 2025 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.